1. Home
  2. PRAX vs ALV Comparison

PRAX vs ALV Comparison

Compare PRAX & ALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$295.56

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo Autoliv Inc.

ALV

Autoliv Inc.

HOLD

Current Price

$104.74

Market Cap

8.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
ALV
Founded
2015
1953
Country
United States
Sweden
Employees
N/A
65200
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
8.9B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
PRAX
ALV
Price
$295.56
$104.74
Analyst Decision
Strong Buy
Buy
Analyst Count
15
10
Target Price
$572.13
$137.10
AVG Volume (30 Days)
298.8K
638.0K
Earning Date
05-01-2026
04-17-2026
Dividend Yield
N/A
3.47%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$2.76
Revenue Next Year
$6,395.88
$3.52
P/E Ratio
N/A
$13.10
Revenue Growth
N/A
N/A
52 Week Low
$26.70
$75.49
52 Week High
$354.87
$130.14

Technical Indicators

Market Signals
Indicator
PRAX
ALV
Relative Strength Index (RSI) 42.98 36.25
Support Level $290.36 N/A
Resistance Level $322.32 $128.33
Average True Range (ATR) 16.81 2.26
MACD -2.42 -0.34
Stochastic Oscillator 26.09 39.29

Price Performance

Historical Comparison
PRAX
ALV

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About ALV Autoliv Inc.

Autoliv Inc is a developer, manufacturer, and supplier of passive safety systems to the automotive industry with a broad range of product offerings. Its product portfolio includes passive safety systems for commercial vehicles, battery cut-off switches, safety solutions for riders of motorcycles and bikes, airbags (including steering wheels and inflators), seatbelts, etc. Geographically, the group operates in the Americas, Europe, China, and Asia, excluding China, of which the maximum revenue is generated from its business in the Americas.

Share on Social Networks: